Johnson & Johnson (LON:0R34)

Market Cap	377.07B
Revenue (ttm)	68.71B
Net Income (ttm)	18.73B
Shares Out	n/a
EPS (ttm)	7.72
PE Ratio	20.13
Forward PE	18.75
Dividend	3.89 (1.85%)
Ex-Dividend Date	Nov 25, 2025

Volume	5,823
Average Volume	31,066
Open	207.31
Previous Close	204.84
Day's Range	204.80 - 211.12
52-Week Range	138.04 - 211.12
Beta	n/a
RSI	71.42
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD